Mizuho analyst Graig Suvannavejh initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $6.
The Latest Analyst Ratings for Hess
Over the past 3 months, 15 analysts have published their opinion on Hess (NYSE:HES) stock. These analysts are…